*The prevalence of TDR to NRTIs (7.3%) was significantly higher than that to PIs (3.0%), p=0.014 and p=0.030. and NNRTIs (6.7%); **The prevalence of TDR to NNRTIs (6.7%) was significantly higher than that to PIs (3.0%), p=0.030 |
||||||||||||||||||||||||||||||||||||
Table 2: Transmitted drug resistance by drug class in new diagnosed HIV infected patients, ECMC, Buffalo, New York, 2005-2011. |